SightfileU.S. market data from official filings

Companies › IBO

IMPACT BIOMEDICAL INC (IBO)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001834105 · EDGAR filings · Updated 2026-05-12

IMPACT BIOMEDICAL INC (IBO) has reported institutional ownership of 3.5%, with 21 institutional managers holding positions valued at $2.23M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
3.5%
Institutional managers
21
Reported 13F value
$2.23M
Insider activity
20 trans.
−$5.29M net selling
Data flags
1 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, IMPACT BIOMEDICAL INC has 21 institutional holders and institutional ownership of 3.5%.

Insider activity

Insiders reported 20 transactions (0 buys, 20 sells) across 6 reporting insiders, with a net reported value of −$5.29M.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-12 (recurring since 2023-10-05) — source filing. The authoritative details are those stated in the filing itself.

Related companies

CEL SCI Corp (CVM) · LONGEVERON INC (LGVN) · MIRA PHARMACEUTICALS INC COM (MIRA) · Outlook Therapeutics Inc (OTLK) · Q/C TECHNOLOGIES INC (QCLS) · SYNERGY CHC CORP (SNYR)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-05-12.